These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26187311)

  • 1. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
    Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
    Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants inhibit Na
    Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
    Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M
    Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.
    Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT
    J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.
    Wang GK; Mitchell J; Wang SY
    J Membr Biol; 2008 Mar; 222(2):79-90. PubMed ID: 18418539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzonatate inhibition of voltage-gated sodium currents.
    Evans MS; Maglinger GB; Fletcher AM; Johnson SR
    Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE; Venton BJ
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Modulation of Na
    Nakatani Y; Amano T
    Biol Pharm Bull; 2018; 41(9):1471-1474. PubMed ID: 30175781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
    Maertens C; Droogmans G; Verbesselt R; Nilius B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):158-65. PubMed ID: 12122503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antidepressant Paroxetine Reduces the Cardiac Sodium Current.
    Plijter IS; Verkerk AO; Wilders R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of S- and R-citalopram to the citalopram-induced modulation of the function of Nav1.5 voltage-gated sodium channels.
    Nakatani Y; Amano T
    Eur J Pharmacol; 2021 Oct; 908():174316. PubMed ID: 34280395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of WB4101, an
    Li M; Wu Y; Zou B; Wang X; Li M; Yu H
    Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
    Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
    Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation differentially modulates the recombinant voltage-gated Na(+) channel α-subunits Nav1.7 and Nav1.8.
    Schlüter F; Leffler A
    Brain Res; 2016 Oct; 1648(Pt A):127-135. PubMed ID: 27450927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
    Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
    Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.